Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Metlife (MET-PF) over the last 17 years, with Q3 2025 value amounting to $308.0 million.

  • Metlife's Gains from Investment Securities rose 1039.43% to $308.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 1077.54%. This contributed to the annual value of $1.6 billion for FY2024, which is 1271.14% down from last year.
  • As of Q3 2025, Metlife's Gains from Investment Securities stood at $308.0 million, which was up 1039.43% from $783.0 million recorded in Q2 2025.
  • In the past 5 years, Metlife's Gains from Investment Securities registered a high of $2.2 billion during Q4 2021, and its lowest value of $35.0 million during Q3 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $308.0 million (2025), whereas its average is $462.0 million.
  • Per our database at Business Quant, Metlife's Gains from Investment Securities tumbled by 7972.6% in 2022 and then surged by 57428.57% in 2023.
  • Over the past 5 years, Metlife's Gains from Investment Securities (Quarter) stood at $2.2 billion in 2021, then tumbled by 79.73% to $444.0 million in 2022, then increased by 8.33% to $481.0 million in 2023, then tumbled by 32.02% to $327.0 million in 2024, then decreased by 5.81% to $308.0 million in 2025.
  • Its Gains from Investment Securities was $308.0 million in Q3 2025, compared to $783.0 million in Q2 2025 and $147.0 million in Q1 2025.